Transforming cancer treatment with Immunotherapy (TechVision)

Fight cancer with Immunotherapy

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Cancer immunotherapy is currently part of a transformative wave that has hit the cancer treatment industry. The progress in this space has been rather substantial on both the technical and commercial front. There have been some high profile FDA approvals for drug candidates, that have shown themselves to be very effective, both as monotherapies and adjunct therapies.

Cancer immunotherapy is essentially garnering one’s own immune system and enabling it with the correct tools to attack and destroy the invasive tumors from within. This form of therapy will result in lesser side effects and would be more beneficial than the conventional treatment options that are there.

The development of these checkpoint inhibitor treatments, cellular immune therapies, as well as cancer vaccines, is playing a crucial role in the pharmaceutical industry.

Table of Contents

Executive SummaryScope Key Findings Cancer Immunotherapy Sneak Peak Cancer Immunotherapy (CI) Cancer Immunotherapy (contd…) Cancer Immunotherapy (contd…) Cancer Immunotherapy (contd…) Cancer Immunotherapy (contd…) Technology Snapshot and Trends Technology Snapshot & Trends Technology Snapshot & Trends (contd…)Technology Snapshot & Trends (contd…)Technology Snapshot & Trends (contd…)Immune Checkpoint ModulationImmune Checkpoint ModulationImmune Checkpoint Modulation (contd…)Immune Checkpoint Modulation (contd…)Immune Checkpoint Modulation (contd…)Immune Checkpoint Modulation (contd…)Immune Checkpoint Modulation (contd…)Cellular Immune TherapyCellular Immune Therapy Cellular Immune Therapy (contd…) Cellular Immune Therapy (contd…) Cellular Immune Therapy (contd…) Cellular Immune Therapy (contd…) Cancer Vaccines Cancer Treatment VaccinesCancer Vaccines (contd…)Cancer Vaccines (contd…)Cancer Vaccines (contd…)Immune Modifying AgentsImmune modifying agents Immune modifying agents Impact Assessment & Analysis Drivers and Restraints Drivers and Restraints (contd…)Drivers and Restraints Impact AssessmentDrivers and Restraints Impact Assessment (contd…) Venture capital investment, Global, 2010-2014 Venture capital investment, Global, 2010-2014 (contd…)Diffusion of InnovationsDiffusion of InnovationDiffusion of Innovation (contd…)Diffusion of Innovation (contd…)Diffusion of Innovation (contd…)Partnerships and Company profiles Partnerships and Collaborations Partnerships and Collaborations (contd…)Company Profiles – Juno Therapeutics Company Profiles – Kite PharmaCompany Profiles – Bellicum PharmaceuticalCompany Profiles – AdvaxisCompany Profiles – AdaptimmunePatents Landscape Patent LandscapePatent Landscape (contd…)Key ContactsKey ContactsKey Contacts (continued)Key Contacts (continued)Legal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.